Search

Your search keyword '"Puccioni-Sohler M"' showing total 113 results

Search Constraints

Start Over You searched for: Author "Puccioni-Sohler M" Remove constraint Author: "Puccioni-Sohler M"
113 results on '"Puccioni-Sohler M"'

Search Results

1. Economic analysis of antenatal screening for human T-cell lymphotropic virus type 1 in Brazil: an open access cost-utility model

3. Optic neuromyelitis syndrome in Brazilian patients. (Paper)

17. Eyelid dystonia in Machado-Joseph disease.

19. Dengue and severe dengue with neurological complications: a challenge for prevention and control.

20. Challenges in the Diagnosis of SARS-CoV-2 Infection in the Nervous System.

21. Review of dengue, zika and chikungunya infections in nervous system in endemic areas.

22. Women living with HTLV-1 should have the opportunity to make informed decisions on prevention of mother-to-child transmission.

23. Economic analysis of antenatal screening for human T-cell lymphotropic virus type 1 in Brazil: an open access cost-utility model.

24. COVID-19 among People Living with HTLV-1 Infection in Rio de Janeiro, Brazil.

25. Human T Lymphotropic Virus 1-Associated Myelopathy: Overview of Human T Cell Lymphotropic Virus-1/2 Tests and Potential Biomarkers.

26. Emerging Monkeypox virus and neuroinflammatory disorders.

28. Cardiovascular risk factors and brain white matter lesions in HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP).

29. Neopterin and CXCL-10 in Cerebrospinal Fluid as Potential Biomarkers of Neuroinvasive Dengue and Chikungunya.

30. Association between high proviral load, cognitive impairment, and white matter brain lesions in HTLV-1-infected individuals.

31. Use of Cerebrospinal Fluid for the Diagnosis of Neuroinvasive Dengue, Zika, and Chikungunya: A 19-year systematic review.

32. Management of HAM/TSP: Systematic Review and Consensus-based Recommendations 2019.

34. Dengue and chikungunya infection in neurologic disorders from endemic areas in Brazil.

35. Health state utility values in people living with HTLV-1 and in patients with HAM/TSP: The impact of a neglected disease on the quality of life.

36. Current evidence of neurological features, diagnosis, and neuropathogenesis associated with COVID-19.

37. Creation and validation of a bladder dysfunction symptom score for HTLV-1-associated myelopathy/tropical spastic paraparesis.

38. Cerebrospinal fluid challenges for the diagnosis of herpes simplex infection in the central nervous system.

40. Increasing awareness of human T-lymphotropic virus type-1 infection: a serious, invisible, and neglected health problem in Brazil.

41. A comparison of nontreponemal tests in cerebrospinal fluid for neurosyphilis diagnosis: equivalent detection of specific antibodies.

42. Importance of cerebrospinal fluid investigation during dengue infection in Brazilian Amazonia Region.

43. Estimation of HTLV-1 vertical transmission cases in Brazil per annum.

44. Cerebrospinal Fluid Immunoglobulins as Potential Biomarkers of Chikungunya Encephalitis.

45. First report of HTLV-1 truncated p12 protein in Brazil.

46. First report of persistent dengue-1-associated autoimmune neurological disturbance: neuromyelitis optica spectrum disorder.

47. Evidence of Sexual Transmission of Human T Cell Lymphotropic Virus Type 1 with ORF-I G29S Mutation Among Humans.

48. Dengue infection in the nervous system: lessons learned for Zika and Chikungunya.

50. A Luminex-based single DNA fragment amplification assay as a practical tool for detecting and serotyping dengue virus.

Catalog

Books, media, physical & digital resources